University of Groningen
Imaging and biomarkers to aid in treatment decisions in melanoma and rectal cancer
Bisschop, Kees
DOI:
10.33612/diss.157532721
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date: 2021
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Bisschop, K. (2021). Imaging and biomarkers to aid in treatment decisions in melanoma and rectal cancer. University of Groningen. https://doi.org/10.33612/diss.157532721
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.
Imaging and biomarkers to aid
in treatment decisions in
melanoma and rectal cancer
The printing of this thesis was financially supported by the Stichting Beroepsopleiding Huisartsen (SBOH), Stichting Werkgroep Interne Oncologie, Rijksuniversiteit Groningen, Universitair Medisch Centrum Groningen, Uitgeverij Jaap, Noord Negentig, and are gratefully acknowledged.
Layout: Douwe Oppewal, www.oppewal.nl Printing: Ipskamp Printing, Enschede
© Copyright 2020, C. Bisschop. All rights reserved. No part of this thesis may be reproduced in any form or by any means without prior permission of the author.
Imaging and biomarkers to aid in
treatment decisions in melanoma
and rectal cancer
Proefschrift
ter verkrijging van de graad van doctor aan de
Rijksuniversiteit Groningen
op gezag van de
rector magnificus prof. dr. C. Wijmenga
en volgens besluit van het College voor Promoties.
De openbare verdediging zal plaatsvinden op
woensdag 31 maart 2021 om 16:15 uur
door
Cornelis Bisschop
geboren op 23 mei 1989
te Elburg
Promotor
Prof. dr. G.A.P. Hospers
Copromotor
Dr. M. Jalving
Beoordelingscommissie
Prof. dr. J.T.M. Plukker Prof. dr. J.B.A.G. Haanen Prof. dr. A.W.J.M. Glaudemans
Paranimfen
Niek Casteleijn Gerwin van Wijhe
Contents
Chapter 1 General introduction and outline of the thesis 9
Chapter 2 Rational use of FDG PET/CT in patients with advanced cutaneous 19 melanoma: a critical review. Crit Rev Oncol Hematol. 2020 Jul; epub
Chapter 3 Rapid BRAF Mutation Tests in Patients with Advanced Melanoma: 51 Comparison of Immunohistochemistry, Droplet Digital Polymerase Chain Reaction and the Idylla Mutation Platform.
Melanoma Res. 2018 Apr;28(2):96-104..
Chapter 4 Serum S100B as a tumor marker of response during treatment 71 with ipilimumab or PD-1 inhibitor.
Chapter 5 Association between pembrolizumab related adverse events and 91 treatment outcome in advanced melanoma: Results from the Dutch expanded access program. J Immunother. 2019 Jul/Aug;42(6):208-214
Chapter 6 Diagnosis and treatment of intestinal melanoma metastases 113 in the era of effective systemic treatment.
Chapter 7 Consequence of restaging after neoadjuvant treatment for 133 locally advanced rectal cancer. Ann Surg Oncol. 2015 Feb;22(2):552-6.
Chapter 8 Short-course radiotherapy followed by neoadjuvant bevacizumab, 147 capecitabine, and oxaliplatin and subsequent radical treatment in primary stage IV rectal cancer. Long-term results of a phase II study.
Ann Surg Oncol. 2017 Sep;24(9):2632-2638.
Chapter 9 Summary 163
Chapter 10 Nederlandse samenvatting (Dutch summary) 171 Dankwoord (Acknowledgments) 179
